Liraglutide for managing overweight and obesity (TA664) Chapter 1: Recommendations
Over time, your skin doesnt just look betterit starts to feel more even, smoother, and easier to manage
CMS requires the prescribing healthcare provider to submit prior authorization confirming that the beneficiary meets the demonstrations eligibility requirements before the medication can be dispensed
GLP-1, or glucagon-like peptide-1, is a hormone released in the intestines in response to food intake
It also stimulates the overexpression of the transient receptor potential melastatin 2 (TRPM2) ion channels, triggering macrophage activation, leading to a systemic immune response
We believe plan sponsors should start preparing now for increased demand and develop a program approach that balances providing access with maintaining benefit affordability.